137 related articles for article (PubMed ID: 20930042)
1. Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients.
Pataer A; Raso MG; Correa AM; Behrens C; Tsuta K; Solis L; Fang B; Roth JA; Wistuba II; Swisher SG
Clin Cancer Res; 2010 Nov; 16(22):5522-8. PubMed ID: 20930042
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.
Guo C; Shao R; Correa AM; Behrens C; Johnson FM; Raso MG; Prudkin L; Solis LM; Nunez MI; Fang B; Roth JA; Wistuba II; Swisher SG; Lin T; Pataer A
J Thorac Oncol; 2013 Mar; 8(3):301-8. PubMed ID: 23370317
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
5. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
Guo C; Hao C; Shao R; Fang B; Correa AM; Hofstetter WL; Roth JA; Behrens C; Kalhor N; Wistuba II; Swisher SG; Pataer A
Oncotarget; 2015 May; 6(13):11114-24. PubMed ID: 25798539
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of CD63 expressionin patients with non-small cell lung cancer.
Koh H; An H; Jung J; Song D
Pol J Pathol; 2019; 70(3):183-188. PubMed ID: 31820861
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
Hansen LV; Skov BG; Ploug M; Pappot H
Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320
[TBL] [Abstract][Full Text] [Related]
9. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples.
Kayser G; Csanadi A; Otto C; Plönes T; Bittermann N; Rawluk J; Passlick B; Werner M
PLoS One; 2013; 8(2):e56333. PubMed ID: 23418554
[TBL] [Abstract][Full Text] [Related]
11. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA Loc344887 is a potential prognostic biomarker in non-small cell lung cancer.
Wu B; Zhang XJ; Li XG; Jiang LS; He F
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3808-3812. PubMed ID: 28975987
[TBL] [Abstract][Full Text] [Related]
13. MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients.
Su CY; Chang YC; Chan YC; Lin TC; Huang MS; Yang CJ; Hsiao M
Eur J Surg Oncol; 2014 Sep; 40(9):1143-50. PubMed ID: 24969958
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
15. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
19. Expression of adiponectin receptor 1 is indicative of favorable prognosis in non-small cell lung carcinoma.
Abdul-Ghafar J; Oh SS; Park SM; Wairagu P; Lee SN; Jeong Y; Eom M; Yong SJ; Jung SH
Tohoku J Exp Med; 2013 Feb; 229(2):153-62. PubMed ID: 23358237
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]